142 related articles for article (PubMed ID: 16394805)
1. Management of multiple intrahepatic recurrences after radiofrequency ablation of hepatocellular carcinoma with rhenium-188-HDD-lipiodol.
Kumar A; Bal C; Srivastava DN; Thulkar SP; Sharma S; Acharya SK; Duttagupta S
Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):219-23. PubMed ID: 16394805
[TBL] [Abstract][Full Text] [Related]
2. Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil.
Kumar A; Srivastava DN; Bal C
J Vasc Interv Radiol; 2006 Jan; 17(1):157-61. PubMed ID: 16415146
[TBL] [Abstract][Full Text] [Related]
3. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
[TBL] [Abstract][Full Text] [Related]
4. Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial.
Kumar A; Srivastava DN; Chau TT; Long HD; Bal C; Chandra P; Chien le T; Hoa NV; Thulkar S; Sharma S; Tam le H; Xuan TQ; Canh NX; Pant GS; Bandopadhyaya GP
Radiology; 2007 May; 243(2):509-19. PubMed ID: 17456873
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma.
Sundram F; Chau TC; Onkhuudai P; Bernal P; Padhy AK
Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708
[TBL] [Abstract][Full Text] [Related]
6. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM
Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
[TBL] [Abstract][Full Text] [Related]
7. (188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.
Lambert B; Bacher K; Defreyne L; Van Vlierberghe H; Jeong JM; Wang RF; van Meerbeeck J; Smeets P; Troisi R; Thierens H; De Vos F; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):344-52. PubMed ID: 16333675
[TBL] [Abstract][Full Text] [Related]
8. Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapy.
Jeong JM; Knapp FF
Semin Nucl Med; 2008 Mar; 38(2):S19-29. PubMed ID: 18243839
[TBL] [Abstract][Full Text] [Related]
9. Empirical 188Re-HDD/lipiodol intra-arterial therapy based on tumor volume, in patients with solitary inoperable hepatocellular carcinoma.
Shinto AS; Karuppusamy KK; Kurup RER; Pandiyan A; Jayaraj AV
Nucl Med Commun; 2021 Jan; 42(1):43-50. PubMed ID: 32956248
[TBL] [Abstract][Full Text] [Related]
10. Ablation of recurrent primary liver cancer using 131I-lipiodol.
Novell R; Hilson A; Hobbs K
Postgrad Med J; 1991 Apr; 67(786):393-5. PubMed ID: 1648718
[TBL] [Abstract][Full Text] [Related]
11. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial.
Lambert B; Bacher K; Defreyne L; Gemmel F; Van Vlierberghe H; Jeong JM; Dierckx RA; Van de Wiele C; Thierens H; De Vos F
J Nucl Med; 2005 Jan; 46(1):60-6. PubMed ID: 15632035
[TBL] [Abstract][Full Text] [Related]
12. International Atomic Energy Agency-sponsored multination study of intra-arterial rhenium-188-labeled lipiodol in the treatment of inoperable hepatocellular carcinoma: results with special emphasis on prognostic value of dosimetric study.
Bernal P; Raoul JL; Stare J; Sereegotov E; Sundram FX; Kumar A; Jeong JM; Pusuwan P; Divgi C; Zanzonico P; Vidmar G; Buscombe J; Chau TT; Saw MM; Chen S; Ogbac R; Dondi M; Padhy AK
Semin Nucl Med; 2008 Mar; 38(2):S40-5. PubMed ID: 18243842
[TBL] [Abstract][Full Text] [Related]
13. Development of 4-hexadecyl-4,7-diaza-1,10-decanedithiol (HDD) kit for the preparation of the liver cancer therapeutic agent Re-188-HDD/lipiodol.
Banka VK; Moon SH; Jeong JM; Seelam SR; Lee YS; Kim YJ; Lee DS; Chung JK
Nucl Med Biol; 2015 Mar; 42(3):317-22. PubMed ID: 25537725
[TBL] [Abstract][Full Text] [Related]
14. 188Re-HDD/lipiodol for treatment of hepatocellular carcinoma: a feasibility study in patients with advanced cirrhosis.
Lambert B; Bacher K; De Keukeleire K; Smeets P; Colle I; Jeong JM; Thierens H; Troisi R; De Vos F; Van de Wiele C
J Nucl Med; 2005 Aug; 46(8):1326-32. PubMed ID: 16085590
[TBL] [Abstract][Full Text] [Related]
15. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model.
Paeng JC; Jeong JM; Yoon CJ; Lee YS; Suh YG; Chung JW; Park JH; Chung JK; Son M; Lee MC
J Nucl Med; 2003 Dec; 44(12):2033-8. PubMed ID: 14660730
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the potential of (188)Re-ECD/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatment.
Luo TY; Shih YH; Chen CY; Tang IC; Wu YL; Kung HC; Lin WJ; Lin XZ
Cancer Biother Radiopharm; 2009 Oct; 24(5):535-41. PubMed ID: 19877883
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
Tang IC; Luo TY; Liu SW; Chan SH; Kung HC; Peng CL; Lin WY; Chang Y; Lin WJ
Nucl Med Biol; 2011 Oct; 38(7):1043-52. PubMed ID: 21831647
[TBL] [Abstract][Full Text] [Related]
18. Two Cases of 188Re Microspheres for Inoperable Hepatocellular Carcinoma.
Shukla J; Kalra N; Kumar R; Bhusari P; Chhabra A; Parmar M; Vatsa R; Singh H; Duseja A; Mittal BR
Clin Nucl Med; 2019 Feb; 44(2):e93-e95. PubMed ID: 30418210
[TBL] [Abstract][Full Text] [Related]
19. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT.
Chopra S; Dodd GD; Chintapalli KN; Leyendecker JR; Karahan OI; Rhim H
AJR Am J Roentgenol; 2001 Aug; 177(2):381-7. PubMed ID: 11461868
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency Ablation Combined With Transarterial Chemoembolization for Specially Located Small Hepatocellular Carcinoma.
Yuan W; Yang MJ; Xu J; Yan ZP; Liu R; Qu XD; Wang JH; Qian S
Technol Cancer Res Treat; 2018 Jan; 17():1533033818788529. PubMed ID: 30045673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
